Evotec offers unique proteomics and metabolomics services to address key issues in drug and biomarker discovery. The Company continuously advances its capabilities in mass spectrometry-based proteomics and metabolomics to ensure unrivalled comprehensiveness and data quality when analysing cells, animal models and patient samples.
The Company’s offering includes:
- Highly optimised experimental strategies tailored to different proteomics applications and project needs
- Industry-leading capabilities in high-end quantitative mass spectrometry
- Experience and infrastructure to analyse the enormous amounts of data generated in large-scale proteomics projects
- Advanced statistics and bioinformatics for systems-wide data analysis
- In-depth data interpretation to extract relevant drug target and mode-of-action information from proteomics experiments
- Extensive track record to deliver high-quality results within agreed timelines
Evotec’s chemical proteomics technologies such as Evotec Cellular Target ProfilingTM reveal cellular drug targets and selectivity in an unbiased manner. Other Evotec proteomics technologies record protein modification and expression on a proteome-wide scale for drug mode-of-action analysis or biomarker discovery efforts. Thus, the Company’s platform offers highly innovative solutions that can be leveraged across the entire drug discovery and development pipeline.
For more detailed information, please click on this link or contact us at email@example.com.